Health Care & Life Sciences » Pharmaceuticals | Parabolic Drugs Ltd.

Parabolic Drugs Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
68
46
7
6
9
Total Accounts Receivable
1,532
1,031
746
713
288
Inventories
3,824
3,198
448
152
159
Other Current Assets
224
221
240
261
282
Total Current Assets
5,647
4,495
1,441
1,133
737
Net Property, Plant & Equipment
4,123
4,019
3,777
3,554
3,329
Total Investments and Advances
1
1
1
1
1
Intangible Assets
4
1
4
1
-
Other Assets
1,377
913
469
151
22
Total Assets
12,443
9,438
5,698
4,848
4,089
ST Debt & Current Portion LT Debt
3,086
3,959
2,416
1,432
1,478
Accounts Payable
1,893
1,026
873
1,000
811
Other Current Liabilities
115
600
1,694
1,700
1,654
Total Current Liabilities
5,094
5,586
4,983
4,132
3,942
Long-Term Debt
5,325
5,614
7,298
8,352
8,353
Provision for Risks & Charges
27
25
15
12
10
Deferred Taxes
1,058
245
290
320
338
Total Liabilities
10,681
11,478
12,595
12,826
12,643
Common Equity (Total)
1,499
2,303
7,160
8,241
8,553
Total Shareholders' Equity
1,499
2,303
7,160
8,241
8,553
Total Equity
1,500
2,303
7,160
8,241
8,553
Liabilities & Shareholders' Equity
12,443
9,438
5,698
4,848
4,089
Accumulated Minority Interest
-
-
-
-
-
Non-Equity Reserves
263
263
263
263
-

About Parabolic Drugs

View Profile
Address
S.C.O 99-100
Chandigarh Chandigarh 160018
India
Employees -
Website http://www.parabolicdrugs.com
Updated 07/08/2019
Parabolic Drugs Ltd. develops and manufactures active pharmaceutical ingredients and intermediates. Its product portfolio includes oral and sterile semi synthetic penicillin active pharmaceutical ingredients, oral and sterile cephalosporin API in antibiotic segment to non-antibiotic API in the cardiovascular, NSAID, anti-hypertensive and osteoporosis segments. The company was founded by Pranav Gupta and Vineet Gupta on February 22, 1996 and is headquartered in Chandigarh, India.